Emma Dunne 💙
@emmadunne
Followers
478
Following
18K
Statuses
2K
Radiation Oncologist BC Cancer, Vancouver (via the NHS). Irish ☘🇮🇪
London
Joined February 2009
0
21
0
RT @ldawsonmd: Proud to see RTOG1112 RCT published!. Thanks to so many who helped make this possible. #teamwork ‘Hope the next #SBRT #HCC…
0
30
0
RT @Mat_Guc: Randomized comparison of SBRT vs RFA for recurrent small HCC (n=166 pts) - Freedom from local progression significantly improv…
0
40
0
RT @NiuSanford: RTOG 1112 finally out! Sorafenib +/- SBRT in HCC. Congrats to @ldawsonmd & team. Brief summary here & some of my thoughts…
0
57
0
RT @NCIEytanRuppin: Are metastatic #cancers more like their normal origin or target tissues? Our work in @ScienceAdvances systematically co…
0
88
0
RT @cristian_udo: Is SBRT the way forward for spine and non-spine bone metastases? Great to work with @SimonLo21054188 @Mat_Guc on this r…
0
23
0
#UKSABR24 thank you for inviting me to speak on #SBRT for non spine bone mets! An inspiring meeting. Fab to meet old friends, mentors & colleagues & great to make some new connections! Roll on Newcastle! (Thanks @PattyDiezH for the photo!).
Cheers from the @SABRconsortium Committee! To an educattional, thought-provoking annual conference. As is tradition some espresso martinis to @YatTsang health! @alison_tree @fifimcdrmh @nickva1 @drdavidpalma @aileen_duffton @fizzy_cyst @emmadunne @Helen__Grimes @rushilkp
1
3
18
RT @NiuSanford: Another setting where SBRT underutilized IMO in HCC is bridge to transplant. I am convinced w modern tech, SBRT can safely…
0
25
0
RT @Dr_Ivanoncologo: Interesting results😱 from the Phase III OPERA trial show that adding contact X-ray brachytherapy (CXB) to chemoradioth…
0
43
0
RT @alison_tree: More great opportunities @ICR_London @royalmarsdenNHS , this time for clinicians wanting to pursue a PhD. Range of project…
0
5
0
RT @MikeChuongMD: 🔥@NRGonc dose escalated #radonc contouring atlas for inoperable #pancreaticcancer in press!🔥 ➡️Step-by-step recs for anat…
0
32
0
RT @KrishanJethwa: 🚨 German Rectal Cancer Study Group informs prognostic significance of ypN+ after nCRT ypN+ (🔥ypN2) associated w/: ⬆️DM…
0
29
0
RT @_ShankarSiva: 🙂 DESTROY-2 trial 🇮🇹 🔥 A quick reminder to those who worry about side effects with single fraction SABR - only 1x Grade 3…
0
51
0
RT @nickva1: The trial was designed in 2011. PACE B and PACE A (recently published @EUplatinum ) designed together. Pt eligibility was ide…
0
3
0
RT @SahgalArjun: The @ISRSy is committed to informing and enhancing global practice in #radiosurgery and #SBRT. Our latest guideline led by…
0
11
0
RT @SahgalArjun: Look out for our two upcoming October @ISRSy webinars, as young stars in the field presenting. Dr. Roman Kowalchuk @MayoCl…
0
16
0
RT @ASTRO_org: New in #practicalRO: Radiosurgery Society Case-Based Guide to Stereotactic Body Radiation Therapy for Challenging Cases of S…
0
17
0
RT @nickva1: Delighted to share the results of #PACE B trial, published in @NEJM today 5 fraction SBRT is non inferior to CRT! https://t.c…
0
165
0
RT @cancerphysicist: How do we talk about (and report) #reirradiation? There's been quite a lot of variation in the literature - including…
0
23
0
RT @SABRconsortium: We’re looking for some new committee members to join us from later this year. Term of office 2024 – 2028. Expressions o…
0
5
0